Fengfeng Cai

1.4k total citations
44 papers, 1.1k citations indexed

About

Fengfeng Cai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fengfeng Cai has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 18 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Fengfeng Cai's work include Cancer Cells and Metastasis (9 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer Genomics and Diagnostics (5 papers). Fengfeng Cai is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer Genomics and Diagnostics (5 papers). Fengfeng Cai collaborates with scholars based in China, Switzerland and United States. Fengfeng Cai's co-authors include Ewelina Biskup, Xiao Yan Zhong, Minghong Wang, Bei Zhang, Weijie Chen, Zeinab Barekati, Xiaoyan Lin, Hongyi Zhang, Haifeng Ye and Weijie Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Immunology.

In The Last Decade

Fengfeng Cai

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengfeng Cai China 19 602 359 289 123 92 44 1.1k
Shuhui Li China 18 834 1.4× 278 0.8× 135 0.5× 85 0.7× 86 0.9× 49 1.2k
Mingli Yang United States 20 876 1.5× 348 1.0× 344 1.2× 57 0.5× 68 0.7× 55 1.3k
X Chen China 20 781 1.3× 168 0.5× 435 1.5× 112 0.9× 55 0.6× 58 1.3k
Jin Zhou China 19 468 0.8× 183 0.5× 213 0.7× 43 0.3× 123 1.3× 47 855
Yuhui Zang China 19 593 1.0× 389 1.1× 121 0.4× 74 0.6× 92 1.0× 44 1.2k
Hongmei Zheng China 21 712 1.2× 435 1.2× 261 0.9× 163 1.3× 136 1.5× 67 1.2k
Xinyue Zhang China 17 853 1.4× 257 0.7× 164 0.6× 48 0.4× 91 1.0× 85 1.3k
Bin Qiao China 18 408 0.7× 188 0.5× 353 1.2× 53 0.4× 90 1.0× 36 874
Laura Pop Romania 19 621 1.0× 416 1.2× 223 0.8× 102 0.8× 129 1.4× 69 1.2k

Countries citing papers authored by Fengfeng Cai

Since Specialization
Citations

This map shows the geographic impact of Fengfeng Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengfeng Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengfeng Cai more than expected).

Fields of papers citing papers by Fengfeng Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengfeng Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengfeng Cai. The network helps show where Fengfeng Cai may publish in the future.

Co-authorship network of co-authors of Fengfeng Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Fengfeng Cai. A scholar is included among the top collaborators of Fengfeng Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengfeng Cai. Fengfeng Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhihao, Di Dai, Xiaoding Ma, et al.. (2025). Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics. Nature Cancer. 6(4). 612–628. 16 indexed citations
2.
Tang, Shasha, et al.. (2025). Harnessing Oncolytic Viruses for Targeted Therapy in Triple-Negative Breast Cancer. International Journal of Medical Sciences. 22(9). 2186–2207. 1 indexed citations
3.
Cai, Fengfeng, et al.. (2024). Single-cell and Spatial Transcriptomic Analyses Implicate Formation of the Immunosuppressive Microenvironment during Breast Tumor Progression. The Journal of Immunology. 213(9). 1392–1401. 3 indexed citations
4.
Zhang, Hongyi, et al.. (2022). Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast. Technology in Cancer Research & Treatment. 21. 2213862974–2213862974. 12 indexed citations
5.
Yang, Chengde, et al.. (2022). Morpho-cultural, physiological and molecular characterisation of Colletotrichum nymphaeae causing anthracnose disease of walnut in China. Microbial Pathogenesis. 166. 105537–105537. 13 indexed citations
6.
Yu, Haixin, et al.. (2022). The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer. Frontiers in Oncology. 12. 964934–964934. 55 indexed citations
7.
Wang, Hui, et al.. (2021). Anticancer Mechanisms of Salinomycin in Breast Cancer and Its Clinical Applications. Frontiers in Oncology. 11. 654428–654428. 42 indexed citations
8.
Zhang, Hongyi, Xiaoyan Lin, Yu‐An Huang, et al.. (2021). Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer. Frontiers in Oncology. 11. 652253–652253. 60 indexed citations
9.
Wang, Xinyi, Kaili Dong, Deqiang Kong, et al.. (2021). A far-red light–inducible CRISPR-Cas12a platform for remote-controlled genome editing and gene activation. Science Advances. 7(50). eabh2358–eabh2358. 35 indexed citations
10.
Cai, Fengfeng, et al.. (2019). Application of Circulation Tumor Cells Detection in Diagnosis and Treatment of Breast Tumors. Rejuvenation Research. 22(6). 498–502. 2 indexed citations
11.
Biskup, Ewelina, Fengfeng Cai, & Marcus Vetter. (2017). Bone targeted therapies in advanced breast cancer. Swiss Medical Weekly. 147(2526). w14440–w14440. 18 indexed citations
12.
Biskup, Ewelina, Fengfeng Cai, Marcus Vetter, & Stephan Märsch. (2017). Oncological patients in the intensive care unit: prognosis, decision-making, therapies and end-of-life care. Swiss Medical Weekly. 147(3132). w14481–w14481. 27 indexed citations
13.
Wu, You, Ping Chen, Chen Wang, et al.. (2015). Microarray Analysis Reveals Potential Biological Functions of Histone H2B Monoubiquitination. PLoS ONE. 10(7). e0133444–e0133444. 9 indexed citations
14.
Cai, Fengfeng, Ping Chen, Li Chen, et al.. (2014). Human RAD6 Promotes G1-S Transition and Cell Proliferation through Upregulation of Cyclin D1 Expression. PLoS ONE. 9(11). e113727–e113727. 18 indexed citations
15.
Zheng, Lihua, Fengfeng Cai, Isabell Ge, Ewelina Biskup, & Zhongping Cheng. (2014). Stromal fibroblast activation and their potential association with uterine fibroids (Review). Oncology Letters. 8(2). 479–486. 18 indexed citations
16.
Lin, Xiaoyan, Fengfeng Cai, Xiaoyan Li, et al.. (2013). Prognostic significance of mammalian sterile 20-like kinase 1 in breast cancer. Tumor Biology. 34(5). 3239–3243. 21 indexed citations
17.
Cai, Fengfeng, Isabell Ge, Minghong Wang, et al.. (2013). Pyrosequencing analysis of BRCA1 methylation level in breast cancer cells. Tumor Biology. 35(4). 3839–3844. 14 indexed citations
18.
Chen, Weijie, Fengfeng Cai, Bei Zhang, Zeinab Barekati, & Xiao Yan Zhong. (2012). The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers. Tumor Biology. 34(1). 455–462. 140 indexed citations
19.
Zhang, Bei, Xueya Wang, Fengfeng Cai, et al.. (2012). Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK. Tumor Biology. 33(6). 1855–1862. 25 indexed citations
20.
Chen, Weijie, Fengfeng Cai, Bei Zhang, & Xiao Yan Zhong. (2011). Strategies of reducing input sample volume for extracting circulating cell-free nuclear DNA and mitochondrial DNA in plasma. Clinical Chemistry and Laboratory Medicine (CCLM). 50(2). 261–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026